Clinical Trial Update: Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of oxaliplatin and capecitabine in advanced esophageal and gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED